Correlation Between Visa and Iterum Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Iterum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Iterum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Iterum Therapeutics PLC, you can compare the effects of market volatilities on Visa and Iterum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Iterum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Iterum Therapeutics.

Diversification Opportunities for Visa and Iterum Therapeutics

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Visa and Iterum is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Iterum Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iterum Therapeutics PLC and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Iterum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iterum Therapeutics PLC has no effect on the direction of Visa i.e., Visa and Iterum Therapeutics go up and down completely randomly.

Pair Corralation between Visa and Iterum Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 3.69 times less return on investment than Iterum Therapeutics. But when comparing it to its historical volatility, Visa Class A is 6.96 times less risky than Iterum Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Iterum Therapeutics PLC is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  117.00  in Iterum Therapeutics PLC on August 27, 2024 and sell it today you would earn a total of  64.00  from holding Iterum Therapeutics PLC or generate 54.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  Iterum Therapeutics PLC

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Iterum Therapeutics PLC 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Iterum Therapeutics PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Iterum Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Visa and Iterum Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Iterum Therapeutics

The main advantage of trading using opposite Visa and Iterum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Iterum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iterum Therapeutics will offset losses from the drop in Iterum Therapeutics' long position.
The idea behind Visa Class A and Iterum Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like